Concepedia

Evan R. Abt

ER

14

Publications

1.1K

Citations

13

H-Index

2013

Active since

Affiliations

University of California, Los Angeles(Current)

China Medical University

Broad Center

Yonsei University

California NanoSystems Institute

Evan R. Abt is an author at University of California, Los Angeles specializing in cell biology, medicine, and cancer metabolism.

ORCID

Top concepts

Publications per year

2013–2024

14

Publications

14

LKB1 Inactivation Dictates Therapeutic Response of Non-Small Cell Lung Cancer to the Metabolism Drug Phenformin

David B. Shackelford, Evan R. Abt, Laurie Gerken et al. · Cancer Cell · 2013 · 567 citations · Full text

, , +11

[<sup>18</sup>F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity

Woo-Suk Kim, Thuc Le, Wei Liu et al. · Proceedings of the National Academy of Sciences · 2016 · 85 citations · Full text

ATR inhibition facilitates targeting of leukemia dependence on convergent nucleotide biosynthetic pathways

Thuc Le, Soumya Poddar, Joseph Capri et al. · Nature Communications · 2017 · 70 citations · Full text

, , +15

Lysosome inhibition sensitizes pancreatic cancer to replication stress by aspartate depletion

Irmina A. Elliott, Amanda M. Dann, Shili Xu et al. · Proceedings of the National Academy of Sciences · 2019 · 51 citations · Full text

Heightening Energetic Stress Selectively Targets LKB1-Deficient Non–Small Cell Lung Cancers

Milica Momcilovic, Robert McMickle, Evan R. Abt et al. · Cancer Research · 2015 · 44 citations · Full text

Rows per page

1–5 of 14